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Zimbabwe is among the top 22 countries in the world with the highest number of pregnant 
women living with HIV, with an estimated HIV prevalence of 16% among women aged between 
15 and 49 years.1 Without any interventions, women living with HIV will pass the infection to 
their infants during pregnancy, labour and delivery in about 15% – 25%2 of the cases, and an 
additional 5% – 20% of the infants may become HIV-infected during breastfeeding.3 Studies 
showed that when combination antiretroviral treatment (cART) is given to the mother for the 
duration of breastfeeding or for life, the risk is reduced further to about 5% or less.4,5 Many factors 
influence the risk of in utero transmission or post-delivery through breastfeeding. These factors 
include high maternal viral load, invasive obstetric procedures and suboptimal infant feeding 
practices.6,7 For example, in the first 6 months of life, the risk of mother-to-child transmission 
(MTCT) in infants who are given other foods in addition to breastmilk is fourfold higher than that 
of infants who are breastfed only.8,9
In 2002, when Zimbabwe launched the prevention of mother-to-child transmission (PMTCT) 
programme, single-dose nevirapine (Sd-NVP) was given to the mother during labour and to 
the infant within 3 days of birth. Women were counselled to exclusively breastfeed for the first 
6 months of an infant’s life.10 Eight years later, following World Health Organization (WHO) 
guidelines which recognised that cART minimises the risk of MTCT of HIV both during pregnancy 
and breastfeeding,11 the antiretroviral treatment (ART) was changed to a combination of 
Zidovudine from 28 weeks of pregnancy with Sd-NVP at the onset of labour and the infant was 
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given Sd-NVP with Zidovudine (dual treatment).12 The WHO 
have updated the ART and infant feeding guidelines three 
times since 2010, considering provision of cART to the mother 
either for the duration of breastfeeding or for life.11,13,14
In an effort to reduce new paediatric HIV infections over the 
years, Zimbabwe’s PMTCT programme has been adopting 
the most recent WHO recommendations on ART and infant 
feeding for women living with HIV. The current guidelines 
recommend lifelong cART for pregnant and breastfeeding 
women living with HIV, regardless of the CD4 count. 
Exclusive breastfeeding is recommended in the first 6 months 
of life with the introduction of complementary feeds and 
continued breastfeeding for 24 months or longer.14 Since the 
end of the last quarter of 2013, Zimbabwe’s Ministry of Health 
Care has supported the use of cART for pregnant women 
and lactating mothers, with a commitment to continue 
lifelong treatment.15,16 Women are started on a combination of 
either Tenofovir + Lamivudine + Efavirenz or Zidovudine + 
Lamivudine + Efavirenz, while the infants are initiated on 
nevirapine for 6 weeks. Women are counselled to exclusively 
breastfeed for the first 6 months of the infant’s life.17
Both small and large clinical trials and observational studies 
have reported MTCT rates at or below 3.5% where ART is 
used in pregnancy and during breastfeeding, with cART 
initiated prior to conception or early in pregnancy being 
associated with the lowest rate of MTCT.18,19
Since the inception of cART for PMTCT in Zimbabwe, little is 
known regarding HIV transmission rates at 6 weeks after 
birth among infants born to women living with HIV. The 
main aim of this study was to assess the effect of maternal 
cART and infant feeding practices on MTCT rates among 
infants born to women living with HIV in Harare, Zimbabwe. 
We also looked at factors that may influence the risk of HIV 
transmission at 6 weeks.
Methods
Study design
We retrospectively reviewed the early infant diagnosis 
National Microbiology Reference Laboratory (NMRL) registry 
(consisting of HIV infection test results) and the maternal 
clinical records of participants enrolled in the PMTCT 
program, over a 2-year period (March 2014 – March 2016). 
The study period was based on the data available after the 
introduction of cART in all Harare City Health polyclinics. 
Study population, setting 
We included HIV-infected women participating in a PMTCT 
programme offered by Harare City Health polyclinics who 
gave birth between March 2014 and March 2016 and were 
receiving ongoing HIV care at the health facilities. Mother–
infant dyads were eligible if the infant was a single child with 
a birth weight greater than or equal to 1500 g, and neither 
mother nor infant had an acutely life-threatening condition 
requiring neonatal admission and intervention. Selection of 
mother–infants pairs dyads was restricted to mothers who 
were at least 16 years of age and whose infant’s 6-week HIV 
infection test results were recorded in the NMRL registry. 
We deliberately chose all the 12 polyclinics under Harare city 
council for feasibility purposes. The polyclinics offer similar 
services which include antenatal care, PMTCT services and 
delivery. The majority of pregnant women attending the 
polyclinics are from the Harare high-density suburbs. 
Sample size
We assumed 5% of the infants would become HIV-infected 6 
weeks following delivery.4,5 Sample size calculation was 
performed using STATA version14 (Stata 14 software; Stata 
Corp., College Station, TX, USA). Calculations were based on 
the power of the Wald test which we set at 0.8, with the null 
and alternative proportions at 0.05 and 0.0707, respectively. 
We set the significance level of 0.05. The a priori sample size 
calculation demonstrated that an estimated sample size of 
1204 participants was needed to conduct the study.
Study measurements and procedures
We compiled a data set on Excel of all entries from the 
early infant diagnosis registry at the National Microbiology 
laboratory comprising 5252 infants referred from the 12 Harare 
polyclinics and tested for HIV using polymerase chain reaction 
(PCR) technology between 2014 and 2016. We performed a 
simple random selection in Stata of 1204 out of the 5252 infants, 
where each infant had an equal probability of being included 
in the study sample. The infant was linked to the mother’s 
clinical records using the name of the infant, the mother’s 
name, the laboratory generated number and the referring 
clinic. The information used to link mother and infant was 
found at the laboratory and the polyclinic. Information with 
participant names was kept in the password-protected 
electronic file. Data were collected on forms where each 
participant was assigned a unique patient identifier linking to 
the information in the electronic file. Data were obtained by 
data abstraction from clinical records. The following data were 
retrieved from the clinical records: ART regimen taken for 
PMTCT, whether or not the infant was on prophylaxis, the 
time at which the mother initiated ART treatment, therapy 
adherence, counselling services offered pre- and post-partum, 
mode of delivery, feeding mode and employment status. 
Clinical definitions
Infants were categorised as exclusively breastfed if they 
receive breastmilk only without other liquids or solids, other 
than the use of oral rehydration solution, vitamins, minerals 
or medicines. Infants were categorised as recipients of 
exclusive replacement feeding if they never received 
breastmilk but were provided with commercial infant 
formula only without other liquids or solids, allowing for the 
same exceptions as noted for exclusive breastfeeding. Mixed 
feeding was defined as combining other liquids or solids 
with either breast milk or infant formula, or a combined 
practice breastmilk and formula feeds.12 Combination 
antiretroviral treatment adherence was defined as taking 
cART every day and exactly as prescribed,20 and the facilities 
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measured this by quantifying missed visits and counting 
medicines returned.
Statistical methods 
Categorical variables were summarised as counts (per cent). 
Multiple logistic regression was used to determine factors 
that are associated with the risk of infant HIV acquisition by 
6 weeks of life. Summary statistics were reported with the 
corresponding 95% confidence intervals (CIs). Statistical 
significance was set at 0.05. Statistical analyses were done 
using Stata version 14 (Stata 14 software; Stata Corp.).
Ethical consideration
Ethics approval was obtained from the Human Health 
Research Ethics Committee of the Stellenbosch University 
(Reference no. S16/04/081), and from the City of Harare 
Ethics Committee and Medical Research Council of 
Zimbabwe (Reference no. MRCZ/B/1086N). Both ethics 
committees approved the research and waiver of consent.
Results
We included 1204 women living with HIV and their infants 
in the analysis. The majority of the infants (94%) included in 
the study were exclusively breastfeeding in the first 6 weeks 
of life. Almost all women had received both pre- and post-
delivery infant feeding counselling. The majority of the 
women were on cART, and most of them started treatment 
during pregnancy (see Table 1).
Of the 1204 infants, 30 (2.5% [95% CI, 1.7–3.5]) were 
HIV-infected. Twenty-two (2%) of 1133 infants who were 
exclusively breastfeeding and eight (13.11%) of 61 infants 
who were mixed feeding were HIV-infected. About 
11 (22%) of 61 of the women practising mixed feeding had 
poor adherence to ART. None of the 10 formula-fed infants 
had a positive HIV DNA PCR test at 6 weeks of life. The 
majority (1166; 97%) of the women had vaginal delivery. 
Of the infants born via normal delivery, 2.5% were 
HIV-infected, and one (2.6%) of 38 infants (2.6%) born via 
Caesarean section was HIV-infected. The women were 
either on cART 1151 (96%), Zidovudine only 24 (2%) or not 
on ART 29 (2%). A higher proportion of infants of mothers 
not on ART (38%) and those on Zidovudine (13%) were 
HIV-infected compared with infants of mothers on 
cART (1%). Levels of HIV infection were infants whose 
mothers started ART before pregnancy (4 of 289; 1.4%) and 
those whose mothers started treatment during pregnancy 
(13 of 841; 1.5%) compared with infants whose mothers 
TABLE 1: Characteristics of HIV-infected women, and their infants (n = 1204) and risk factors associated with HIV infection.




95% CI p Adjusted 
odds ratio
95% CI p
Mode of delivery 
Normal delivery 1166 97 29 1 - - - - -
Caesarean section 38 3 1 1.06 0.14–7.99 0.95 - - -
Employment status 
Yes 31 3 0 - - - - - -
No 1173 97 29 - - - - - -
†Antiretroviral treatment adherence 
No 20 2 14 1 - - 1 - -
Yes 1155 98 14 0.03 0.01–0.08 < 0.001 0.01 0.00–0.06 < 0.001
†Pre-partum counselling
No 23 2 10 1 - - 1 - -
Yes 1181 98 19 0.02 0.01–0.06 < 0.001 0.65 0.6–7.14 0.72
Post-partum counselling
No 10 1 10 - - - - - -
Yes 1194 99 19 - - - - - -
†Feeding type
Exclusive breast feeding 1133 94 22 1 - - 1 - -
Replacement feeding 10 1 0 - - - - - -
Ever mixed breast feeding 61 5 8 7.62 3.24–17.9 < 0.001 3.89 0.92–16.50 0.06
Prophylaxis (baby)
No 14 1 8 - - - - - -
Yes 1190 99 22 - - - - - -
†ART regiment (mother)
Tenofovir + Lamivudine + Efavirenz (Tenolam-E) 1151 96 16 1 - - 1 - -
None 29 2 11 43.35 17.7–106.40 < 0.001 - - -
Zidovudine (AZT) 24 2 3 10.13 2.74–37.43  0.001 0.17 0.02–1.46 0.11
†Time ART treatment started
Before pregnancy 289 - 4 1 - - 1 - -
During pregnancy 841 - 13 1.11 0.36–3.46 0.85 1.01 0.31–3.32 0.99
After pregnancy 38 3 2 3.96 0.70–22.38 0.12 3.18 0.42–23.94 0.07
Unknown 36 3 0 - - - - - -
ART, Antiretroviral treatment.
†, Variables entered into the multiple logistic regression model.
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started ART after delivery (2 of 38; 5.3%) and those whose 
mothers were not on ART (11 of 36; 30.5%). 
Adherence to ART reduced the odds of HIV infection by 
about 99% (odds ratio [OR] 0.01 [95% CI, 0.00–0.06]). Infants 
of mothers who started ART after delivery were three times 
as likely to be infected compared with those of mothers who 
started ART before pregnancy. The adjusted odds ratios for 
mothers who were on Zidovudine and for those mothers 
who started ART after delivery did not reach statistical 
significance. Mixed feeding had a borderline quadrupled 
odds of HIV infection compared with exclusive breastfeeding 
with a large confidence interval (OR 3.89 [95% CI, 0.92–16.50]) 
(see Table 1).
Discussion
In this population of women living with HIV, of whom 96% 
accessed cART, we found a very low overall MTCT rate at 
6 weeks of life. Combination antiretroviral treatment prior to 
conception or in pregnancy, cART adherence and exclusive 
formula feeding were associated with a low risk of HIV 
acquisition.
We also found that most (71%) of the women started cART 
during pregnancy. However, there were a few women (3%) 
who started cART after delivery, the infants of these women 
had a non-significant threefold odds of HIV infection 
compared with infants of women who started treatment 
before pregnancy. A larger sample size may have resulted in 
statistical significance. Late initiation of maternal ART was 
previously shown to be associated with the vertical 
transmission of HIV and infant mortality.21,22,23,24 It is unclear 
why these women were initiated on treatment lately. One 
possible reason could be that these women may have 
presented at the primary healthcare centre later in pregnancy, 
when they were in labour.25 A few women (2%) were not on 
ART. While these findings are encouraging, the Zimbabwe 
PMTCT programme needs to put more effort on having all 
women on ART soon after HIV diagnosis. These efforts are 
likely to further reduce the 6-week MTCT of HIV. 
The current WHO infant feeding guidelines recommend 
breastfeeding even in the presence of mixed feeding.14 This 
recommendation was based on limited information on 
whether mixed feeding remains a risk for postnatal HIV 
transmission even in the presence of cART.26,27 Mixed-fed 
infants in our study had a statistically insignificant, but 
clinically important higher odds of HIV infection than 
exclusively breastfed infants, suggesting that the possibility 
of mixed feeding remains a risk even in the presence 
of cART. A large study would probably have achieved 
statistical significance. It is of concern that close to a quarter 
of the women practising mixed feeding had poor adherence 
to ART. Mixed feeding should therefore remain a concern 
for PMTCT programmes, and efforts should be made 
to promote and support exclusive breastfeeding for 
HIV-exposed infants. 
Our study had several limitations. We used routinely 
collected data, and this limited us in determining the number 
of HIV infections that occurred during pregnancy and 
delivery and those that occurred through breastfeeding. We 
could not assess other factors that could influence the risk of 
HIV infection such as maternal viral load, or maternal age as 
they were not available in the reviewed clinical records. We 
did not account for ‘within clinic clustering’, which could 
influence the outcome. Our results may not be generalisable 
to infants who are premature and sick neonates who are at 
higher risk for HIV transmission.
Conclusion
Despite the limitations of our study, the findings suggest that 
cART from conception or when initiated during pregnancy 
reduces the MTCT of HIV to levels similar to those found in 
controlled trial settings. Exclusive breastfeeding remains 
important even in the presence of ART. 
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